February 28 at 5 pm (Lisbon Time)
Chairs: Mariana Monteiro and Jorge Sequeiros
Title: Prof. Duncan and "The Genetics Revolution in Endocrinology: Translating Basic Research into Meaningful Clinical Outcomes in Bone Diseases and Beyond" & Prof. Brown and the "Translating Rare Disease and Cancer Genomics into the Clinic. The Genomics England Perspective"

Professor Matt Brown is a clinician-scientist who trained initially in medicine and rheumatology in Sydney, Australia before completing a Doctorate of Medicine based at University of Oxford, focusing on genetics of ankylosing spondylitis. He was appointed Professor of Musculoskeletal Sciences at University of Oxford in 2004. In 2005 Matt returned to Australia, firstly to University of Queensland, and since 2016, at Queensland University of Technology, where he was Professor and Director of Genomics. In 2013 he was elected to Fellowship of the Australian Academy of Sciences in recognition for his achievements in genetics research. In 2019 he moved to King’s College London and Guy’s and St Thomas’ Hospitals NHS Trust to direct their NIHR Biomedical Research Centre, and in 2021 moved to the position of Chief Scientific Officer of Genomics England. He continues to work in genetics of human diseases, with a particular focus on common and rare bone and joint diseases, and in cancer genomics and personalized medicine. He continues to practice rheumatology, with a particular focus on spondyloarthritis.________________________________________________________________________________________________________________________________________________________ Professor Emma Duncan is a clinician-scientist, currently appointed as Professor of Clinical Endocrinology at King’s College London and Honorary Specialist Physician in the Department of Endocrinology, Guy’s and St Thomas’ NHS Foundation Trust. After training in medicine at the University of Sydney, she moved to the UK in 1994, where she undertook her doctorate into the genetics of osteoporosis, (based at the University of Oxford and in collaboration with the Open University) and completed her speciality training. Returning to Australia in 2005, Emma held professorial appointments at both University of Queensland and Queensland University of Technology and was Pre-Eminent Senior Staff Specialist at Royal Brisbane and Women’s Hospital. In 2020 she moved back to the UK for her current position. Since her undergraduate days Emma has been fascinated by endocrinology in general and bone in particular. Her basic research spans the genetics of many endocrine disorders, from common variant to rare monogenic diseases, and she is actively engaged in translating genetic technologies into clinical practice. Emma has also led many clinical research projects in diabetes and endocrinology; and she is a thought-leader in bone diseases internationally. Emma contributes to leadership and governance nationally and internationally, and has served as President of the Australian and New Zealand Bone and Mineral Society, Councillor for the American Society for Bone and Mineral Research, and Associate Editor for the Journal of Bone and Mineral Research and Endocrine Reviews. During the pandemic she established and led multiple studies in COVID-19, including studies of SARS-CoV-2 in children and the genetics of the post-COVID syndrome, and she co-created the COVID Symptom Study Biobank. As the pandemic subsides, she is enjoying returning to genomics- and endocrine-focused research.


Are you ready to take the next step toward your future career?